Molecular diagnosis and therapy for occult peritoneal metastasis in gastric cancer patients

World Journal of Gastroenterology

Volumn 20, Issue 47, 2014, Pages 17796-17803

  Kagawa, Shunsuke ^a   Shigeyasu, Kunitoshi ^a   Ishida, Michihiro ^a   Watanabe, Megumi ^a   Tazawa, Hiroshi ^a   Nagasaka, Takeshi ^a   Shirakawa, Yasuhiro ^a   Fujiwara, Toshiyoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Carcinoembryonic antigen; Cytology; Gastric cancer; Molecular diagnostic techniques; Peritoneal lavage; Reverse transcriptase polymerase chain reaction

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; TELOMERASE; TUMOR MARKER;

ARTICLE; CANCER CELL; CANCER STAGING; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; GENETIC ANALYSIS; HUMAN; MEDICAL DECISION MAKING; MOLECULAR DIAGNOSIS; PERITONEAL CAVITY; PERITONEAL FLUID; PERITONEUM LAVAGE; PERITONEUM METASTASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; CHEMISTRY; FLOW CYTOMETRY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; IMMUNOASSAY; PATHOLOGY; PERITONEAL NEOPLASMS; PERSONALIZED MEDICINE; PHENOTYPE; PREDICTIVE VALUE; PROGNOSIS; SECONDARY; STOMACH NEOPLASMS; TUMOR INVASION;

BIOMARKERS, TUMOR; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; IMMUNOASSAY; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM INVASIVENESS; PERITONEAL NEOPLASMS; PHENOTYPE; PRECISION MEDICINE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84919773525     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i47.17796     Document Type: Article

References (70)

1. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC Cancer Base No.10. Available from: URL: http://globocan.iarc.fr
2. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013; 132: 1133-1145 [PMID: 22752881 DOI: 10.1002/ijc.27711]
3. Coburn N, Seevaratnam R, Paszat L, Helyer L, Law C, Swallow C, Cardosa R, Mahar A, Lourenco LG, Dixon M, Bekaii-Saab T, Chau I, Church N, Coit D, Crane CH, Earle C, Mansfield P, Marcon N, Miner T, Noh SH, Porter G, Posner MC, Prachand V, Sano T, van de Velde C, Wong S, McLeod R. Optimal management of gastric cancer: results from an international RAND/UCLA expert panel. Ann Surg 2014; 259: 102-108 [PMID: 23478525 DOI: 10.1097/SLA.0b013e318288dd2b]
4. Brar SS, Mahar AL, Helyer LK, Swallow C, Law C, Paszat L, Seevaratnam R, Cardoso R, McLeod R, Dixon M, Yohanathan L, Lourenco LG, Bocicariu A, Bekaii-Saab T, Chau I, Church N, Coit D, Crane CH, Earle C, Mansfield P, Marcon N, Miner T, Noh SH, Porter G, Posner MC, Prachand V, Sano T, van de Velde C, Wong S, Coburn NG. Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND/UCLA expert panel. JAMA Surg 2014; 149: 18-25 [PMID: 24225775 DOI: 10.1001/jamasurg.2013.3959]
5. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 2010; 17: 3077-3079 [PMID: 20882416 DOI: 10.1245/s10434-010-1362-z]
6. Sobin L GM, Wittekind C. TNM Classifcation of Malignant Tumours, 7th ed. Oxford: Wiley-Blackwell, 2009
7. Lee SD, Ryu KW, Eom BW, Lee JH, Kook MC, Kim YW. Prognostic significance of peritoneal washing cytology in patients with gastric cancer. Br J Surg 2012; 99: 397-403 [PMID: 22101572 DOI: 10.1002/bjs.7812]
8. La Torre M, Ferri M, Giovagnoli MR, Sforza N, Cosenza G, Giarnieri E, Ziparo V. Peritoneal wash cytology in gastric carcinoma. Prognostic significance and therapeutic consequences. Eur J Surg Oncol 2010; 36 : 982-986 [PMID: 20591604 DOI: 10.1016/j.ejso.2010.06.007]
9. Nakagohri T, Yoneyama Y, Kinoshita T, Konishi M, Inoue K, Takahashi S. Prognostic significance of peritoneal washing cytology in patients with potentially resectable gastric cancer. Hepatogastroenterology 2008; 55: 1913-1915 [PMID: 19102421]
10. Euanorasetr C, Lertsithichai P. Prognostic significance of peritoneal washing cytology in Thai patients with gastric adenocarcinoma undergoing curative D2 gastrectomy. Gastric Cancer 2007; 10: 18-23 [PMID: 17334713 DOI: 10.1007/s10120-006-0402-7]
11. Yajima K, Kanda T, Ohashi M, Wakai T, Nakagawa S, Sasamoto R, Hatakeyama K. Clinical and diagnostic significance of preoperative computed tomography findings of ascites in patients with advanced gastric cancer. Am J Surg 2006; 192: 185-190 [PMID: 16860627 DOI: 10.1016/j.amjsurg.2006.05.007]
12. Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T. Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol 1999; 72: 60-64; discussion 64-65 [PMID: 10518099]
13. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011; 14: 101-112 [PMID: 21573743 DOI: 10.1007/s10120-011-0041-5]
14. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011; 14: 113-123 [PMID: 21573742 DOI: 10.1007/s10120-011-0042-4]
15. Mezhir JJ, Shah MA, Jacks LM, Brennan MF, Coit DG, Strong VE. Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Indian J Surg Oncol 2011; 2: 16-23 [PMID: 22696066 DOI: 10.1007/s13193-011-0074-6]
16. Fukagawa T, Katai H, Saka M, Morita S, Sasajima Y, Taniguchi H, Sano T, Sasako M. Significance of lavage cytology in advanced gastric cancer patients. World J Surg 2010; 34: 563-568 [PMID: 20054543 DOI: 10.1007/s00268-009-0355-1]
17. Miyashiro I, Takachi K, Doki Y, Ishikawa O, Ohigashi H, Murata K, Sasaki Y, Imaoka S, Nakaizumi A, Takenaka A, Furukawa H, Hiratsuka M. When is curative gastrectomy justified for gastric cancer with positive peritoneal lavage cytology but negative macroscopic peritoneal implant? World J Surg 2005; 29: 1131-1134 [PMID: 16086213 DOI: 10.1007/s00268-005-7703-6]
18. Mezhir JJ, Posner MC, Roggin KK. Prospective clinical trial of diagnostic peritoneal lavage to detect positive peritoneal cytology in patients with gastric cancer. J Surg Oncol 2013; 107: 794-798 [PMID: 23532564 DOI: 10.1002/jso.23328]
19. Fujiwara Y, Doki Y, Taniguchi H, Sohma I, Takiguchi S, Miyata H, Yamasaki M, Monden M. Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: present status and future perspectives. Gastric Cancer 2007; 10: 197-204 [PMID: 18095074 DOI: 10.1007/s10120-007-0436-5]
20. Leake PA, Cardoso R, Seevaratnam R, Lourenco L, Helyer L, Mahar A, Rowsell C, Coburn NG. A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer. Gastric Cancer 2012; 15 Suppl 1: S27-S37 [PMID: 21809111 DOI: 10.1007/s10120-011-0071-z]
21. Moore GE, Sako K, Kondo T, Badillo J, Burke E. Assessment of the exfoliation of tumor cells into the body cavities. Surg Gynecol Obstet 1961; 112: 469-474 [PMID: 13772295]
22. Suzuki T, Ochiai T, Hayashi H, Nakajima K, Yasumoto A, Hishikawa E, Shimada H, Horiuchi F, Ohki S, Isono K. Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer. Surg Today 1999; 29: 111-115 [PMID: 10030734]
23. Makino T, Fujiwara Y, Takiguchi S, Miyata H, Yamasaki M, Nakajima K, Nishida T, Mori M, Doki Y. The utility of preoperative peritoneal lavage examination in serosa-invading gastric cancer patients. Surgery 2010; 148 : 96-102 [PMID: 20096433 DOI: 10.1016/j.surg.2009.11.025]
24. Bonenkamp JJ, Songun I, Hermans J, van de Velde CJ. Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg 1996; 83: 672-674 [PMID: 8689216]
25. Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu Y, Fushida S, Fujimura T, Nishimura G, Miwa K. Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 1999; 178: 256-262 [PMID: 10527450]
26. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition - Gastric Cancer 1998; 1: 10-24 [PMID: 11957040 DOI: 10.1007/s101209800016]
27. Network NCC. NCCN guideline: gastric cancer. Available from: URL: http://www.nccn.org
28. Wu CC, Chen JT, Chang MC, Ho WL, Chen CY, Yeh DC, Liu TJ, P'eng FK. Optimal surgical strategy for potentially curable serosa-involved gastric carcinoma with intraperitoneal free cancer cells. J Am Coll Surg 1997; 184: 611-617 [PMID: 9179118]
29. Kanetaka K, Ito S, Susumu S, Yoneda A, Fujita F, Takatsuki M, Kuroki T, Eguchi S. Clinical significance of carcinoembryonic antigen in peritoneal lavage from patients with gastric cancer. Surgery 2013; 154: 563-572 [PMID: 23806263 DOI: 10.1016/j.surg.2013.03.005]
30. Asao T, Fukuda T, Yazawa S, Nagamachi Y. Carcinoembryonic antigen levels in peritoneal washings can predict peritoneal recurrence after curative resection of gastric cancer. Cancer 1991; 68: 44-47 [PMID: 2049751]
31. Abe N, Watanabe T, Toda H, Machida H, Suzuki K, Masaki T, Mori T, Sugiyama M, Atomi Y, Nakaya Y. Prognostic significance of carcinoembryonic antigen levels in peritoneal washes in patients with gastric cancer. Am J Surg 2001; 181: 356-361 [PMID: 11438272]
32. Irinoda T, Terashima M, Takagane A, Sasaki N, Abe K, Araya M, Nishizuka S, Yonezawa H, Nakaya T, Shimooki O, Oyama K, Ikeda K, Saito K. Carcinoembryonic antigen level in peritoneal washing is a prognostic factor in patients with gastric cancer. Oncol Rep 1998; 5: 661-666 [PMID: 9538172]
33. Yamamoto M, Baba H, Toh Y, Okamura T, Maehara Y. Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients. J Cancer Res Clin Oncol 2007; 133: 471-476 [PMID: 17226046 DOI: 10.1007/s00432-006-0189-2]
34. Cetin B, Atalay C, Aslan S, Babacan B, Hatipo?lu C, Akinci M, Cetin A. Peritoneal carcinoembryonic antigen level for predicting locoregional and distant spread of gastric cancer. Surg Today 2005; 35: 919-924 [PMID: 16249844 DOI: 10.1007/s00595-005-3057-9]
35. Li JK, Zheng M, Miao CW, Zhang JH, Ding GH, Wu WS. Peritoneal lavage cytology and carcinoembryonic antigen determination in predicting peritoneal metastasis and prognosis of gastric cancer. World J Gastroenterol 2005; 11: 7374-7377 [PMID: 16437646]
36. Wang JY, Lin SR, Lu CY, Chen CC, Wu DC, Chai CY, Chen FM, Hsieh JS, Huang TJ. Gastric cancer cell detection in peritoneal lavage: RT-PCR for carcinoembryonic antigen transcripts versus the combined cytology with peritoneal carcinoembryonic antigen levels. Cancer Lett 2005; 223: 129-135 [PMID: 15890245 DOI: 10.1016/j.canlet.2004.09.031]
37. Dalal KM, Woo Y, Kelly K, Galanis C, Gonen M, Fong Y, Coit DG. Detection of micrometastases in peritoneal washings of gastric cancer patients by the reverse transcriptase polymerase chain reaction. Gastric Cancer 2008; 11: 206-213 [PMID: 19132482 DOI: 10.1007/s10120-008-0483-6]
38. Kodera Y, Nakanishi H, Ito S, Yamamura Y, Kanemitsu Y, Shimizu Y, Hirai T, Yasui K, Kato T, Tatematsu M. Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: a sensitive predictor of outcome for patients with gastric carcinoma. Ann Surg 2002; 235: 499-506 [PMID: 11923605]
39. Yonemura Y, Fujimura T, Ninomiya I, Kim BS, Bandou E, Sawa T, Kinoshita K, Endo Y, Sugiyama K, Sasaki T. Prediction of peritoneal micrometastasis by peritoneal lavaged cytology and reverse transcriptase-polymerase chain reaction for matrix metalloproteinase-7 mRNA. Clin Cancer Res 2001; 7: 1647-1653 [PMID: 11410502]
40. Kodera Y, Nakanishi H, Ito S, Yamamura Y, Fujiwara M, Koike M, Hibi K, Ito K, Tatematsu M, Nakao A. Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of carcinoembryonic antigen. Gastric Cancer 2005; 8: 142-148 [PMID: 16086116 DOI: 10.1007/s10120-005-0318-7]
41. Sugita Y, Fujiwara Y, Taniguchi H, Mori T, Ishii T, Niwa H, Okada Y, Takiguchi S, Yasuda T, Yano M, Monden M. Quantitative molecular diagnosis of peritoneal lavage fluid for prediction of peritoneal recurrence in gastric cancer. Int J Oncol 2003; 23: 1419-1423 [PMID: 14532985]
42. Takata A, Kurokawa Y, Fujiwara Y, Nakamura Y, Takahashi T, Yamasaki M, Miyata H, Nakajima K, Takiguchi S, Mori M, Doki Y. Prognostic value of CEA and CK20 mRNA in the peritoneal lavage fluid of patients undergoing curative surgery for gastric cancer. World J Surg 2014; 38: 1107-1111 [PMID: 24305936 DOI: 10.1007/s00268-013-2385-y]
43. Mori K, Suzuki T, Uozaki H, Nakanishi H, Ueda T, Matsuno Y, Kodera Y, Sakamoto H, Yamamoto N, Sasako M, Kaminishi M, Sasaki H. Detection of minimal gastric cancer cells in peritoneal washings by focused microarray analysis with multiple markers: clinical implications. Ann Surg Oncol 2007; 14: 1694-1702 [PMID: 17294072 DOI: 10.1245/s10434-006-9321-4]
44. Mori K, Aoyagi K, Ueda T, Danjoh I, Tsubosa Y, Yanagihara K, Matsuno Y, Sasako M, Sakamoto H, Mafune Ki, Kaminishi M, Yoshida T, Terada M, Sasaki H. Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings. Biochem Biophys Res Commun 2004; 313: 931-937 [PMID: 14706632]
45. Castellano I, Macrì L, Deambrogio C, Balmativola D, Bussone R, Ala A, Coluccia C, Sapino A. Reliability of whole sentinel lymph node analysis by one-step nucleic acid amplification for intraoperative diagnosis of breast cancer metastases. Ann Surg 2012; 255: 334-342 [PMID: 21975319 DOI: 10.1097/SLA.0b013e31823000ed]
46. Matsuzuka T, Takahashi K, Kawakita D, Kohno N, Nagafuji H, Yamauchi K, Suzuki M, Miura T, Furuya N, Yatabe Y, Matsuo K, Omori K, Hasegawa Y. Intraoperative molecular assessment for lymph node metastasis in head and neck squamous cell carcinoma using one-step nucleic acid amplification (OSNA) assay. Ann Surg Oncol 2012; 19: 3865-3870 [PMID: 22618721 DOI: 10.1245/s10434-012-2409-0]
47. Tamaki Y, Sato N, Homma K, Takabatake D, Nishimura R, Tsujimoto M, Yoshidome K, Tsuda H, Kinoshita T, Kato H, Taniyama K, Kamio T, Nakamura S, Akiyama F, Noguchi S. Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: results of a multicenter study in Japan. Cancer 2012; 118: 3477-3483 [PMID: 22252672 DOI: 10.1002/cncr.26683]
48. Yaguchi Y, Sugasawa H, Tsujimoto H, Takata H, Nakabayashi K, Ichikura T, Ono S, Hiraki S, Sakamoto N, Horio T, Kumano I, Otomo Y, Mochizuki H, Yamamoto J, Hase K. One-step nucleic acid amplification (OSNA) for the application of sentinel node concept in gastric cancer. Ann Surg Oncol 2011; 18: 2289-2296 [PMID: 21301968 DOI: 10.1245/s10434-011-1591-9]
49. Muto Y, Matubara H, Tanizawa T, Nabeya Y, Kawahira H, Akai T, Hoshino I, Hayashi H. Rapid diagnosis of micrometastasis of gastric cancer using reverse transcription loop-mediated isothermal amplification. Oncol Rep 2011; 26: 789-794 [PMID: 21769432 DOI: 10.3892/or.2011.1389]
50. Kumagai K, Yamamoto N, Miyashiro I, Tomita Y, Katai H, Kushima R, Tsuda H, Kitagawa Y, Takeuchi H, Mukai M, Mano M, Mochizuki H, Kato Y, Matsuura N, Sano T. Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients. Gastric Cancer 2014; 17: 273-280 [PMID: 23743877 DOI: 10.1007/s10120-013-0271-9]
51. Nagasaka T, Tanaka N, Cullings HM, Sun DS, Sasamoto H, Uchida T, Koi M, Nishida N, Naomoto Y, Boland CR, Matsubara N, Goel A. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. J Natl Cancer Inst 2009; 101: 1244-1258 [PMID: 19700653 DOI: 10.1093/jnci/djp265]
52. Hiraki M, Kitajima Y, Koga Y, Tanaka T, Nakamura J, Hashiguchi K, Noshiro H, Miyazaki K. Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients. Ann Surg Oncol 2011; 18: 3013-3019 [PMID: 21409489 DOI: 10.1245/s10434-011-1636-0]
53. Hiraki M, Kitajima Y, Sato S, Nakamura J, Hashiguchi K, Noshiro H, Miyazaki K. Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer. World J Gastroenterol 2010; 16: 330-338 [PMID: 20082478]
54. Kishimoto H, Kojima T, Watanabe Y, Kagawa S, Fujiwara T, Uno F, Teraishi F, Kyo S, Mizuguchi H, Hashimoto Y, Urata Y, Tanaka N, Fujiwara T. In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus. Nat Med 2006; 12: 1213-1219 [PMID: 17013385 DOI: 10.1038/nm1404]
55. Kojima T, Hashimoto Y, Watanabe Y, Kagawa S, Uno F, Kuroda S, Tazawa H, Kyo S, Mizuguchi H, Urata Y, Tanaka N, Fujiwara T. A simple biological imaging system for detecting viable human circulating tumor cells. J Clin Invest 2009; 119: 3172-3181 [PMID: 19729837 DOI: 10.1172/JCI38609]
56. Mori N, Oka M, Hazama S, Iizuka N, Yamamoto K, Yoshino S, Tangoku A, Noma T, Hirose K. Detection of telomerase activity in peritoneal lavage fluid from patients with gastric cancer using immunomagnetic beads. Br J Cancer 2000; 83: 1026-1032 [PMID: 10993650 DOI: 10.1054/bjoc.2000.1408]
57. Da MX, Wu XT, Guo TK, Zhao ZG, Luo T, Qian K, Zhang MM, Wang J. Clinical significance of telomerase activity in peritoneal lavage fluid from patients with gastric cancer and its relationship with cellular proliferation. World J Gastroenterol 2007; 13: 3122-3127 [PMID: 17589931]
58. Kitayama J, Emoto S, Yamaguchi H, Ishigami H, Kamei T, Yamashita H, Seto Y, Matsuzaki K, Watanabe T. Flow cytometric quantification of intraperitoneal free tumor cells in patients with peritoneal metastasis. Cytometry B Clin Cytom 2014; 86: 56-62 [PMID: 24115348 DOI: 10.1002/cyto.b.21126]
59. Peterson VM, Castro CM, Chung J, Miller NC, Ullal AV, Castano MD, Penson RT, Lee H, Birrer MJ, Weissleder R. Ascites analysis by a microfluidic chip allows tumor-cell profiling. Proc Natl Acad Sci USA 2013; 110: E4978-E4986 [PMID: 24297935 DOI: 10.1073/pnas.1315370110]
60. Adusumilli PS, Gholami S, Chun YS, Mullerad M, Chan MK, Yu Z, Ben-Porat L, Rusch VW, Fong Y. Fluorescence-assisted cytological testing (FACT): Ex Vivo viral method for enhancing detection of rare cancer cells in body fluids. Mol Med 2011; 17 : 628-634 [PMID: 21487639 DOI: 10.2119/molmed.2011.00078]
61. Maida Y, Kyo S, Sakaguchi J, Mizumoto Y, Hashimoto M, Mori N, Ikoma T, Nakamura M, Takakura M, Urata Y, Fujiwara T, Inoue M. Diagnostic potential and limitation of imaging cancer cells in cytological samples using telomerase-specific replicative adenovirus. Int J Oncol 2009; 34: 1549-1556 [PMID: 19424572]
62. Wong J, Schulman A, Kelly K, Zamarin D, Palese P, Fong Y. Detection of free peritoneal cancer cells in gastric cancer using cancer-specific Newcastle disease virus. J Gastrointest Surg 2010; 14: 7-14 [PMID: 19902312 DOI: 10.1007/s11605-009-1071-8]
63. Kodera Y, Ito S, Mochizuki Y, Ohashi N, Tanaka C, Kobayashi D, Kojima H, Matsui T, Kondo K, Fujiwara M. Longterm follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study. Gastric Cancer 2012; 15: 335-337 [PMID: 22527184 DOI: 10.1007/s10120-012-0156-3]
64. Kodera Y, Ito S, Mochizuki Y, Kondo K, Koshikawa K, Suzuki N, Kojima H, Kojima T, Matsui T, Takase T, Tsuboi K, Fujiwara M, Nakao A. A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study). Eur J Surg Oncol 2009; 35: 1158-1163 [PMID: 19328643 DOI: 10.1016/j.ejso.2009.03.003]
65. Yamaguchi H, Kitayama J, Ishigami H, Emoto S, Yamashita H, Watanabe T. A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis. Cancer 2013; 119: 3354-3358 [PMID: 23798046 DOI: 10.1002/cncr.28204]
66. Kitayama J, Ishigami H, Yamaguchi H, Yamashita H, Emoto S, Kaisaki S, Watanabe T. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites. Ann Surg Oncol 2014; 21: 539-546 [PMID: 23975319 DOI: 10.1245/s10434-013-3208-y]
67. Litvinov SV, Velders MP, Bakker HA, Fleuren GJ, Warnaar SO. Ep-CAM: a human epithelial antigen is a homophilic cellcell adhesion molecule. J Cell Biol 1994; 125: 437-446 [PMID: 8163559]
68. Went P, Vasei M, Bubendorf L, Terracciano L, Tornillo L, Riede U, Kononen J, Simon R, Sauter G, Baeuerle PA. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer 2006; 94: 128-135 [PMID: 16404366 DOI: 10.1038/sj.bjc.6602924]
69. Heiss MM, Murawa P, Koralewski P, Kutarska E, Kolesnik OO, Ivanchenko VV, Dudnichenko AS, Aleknaviciene B, Razbadauskas A, Gore M, Ganea-Motan E, Ciuleanu T, Wimberger P, Schmittel A, Schmalfeldt B, Burges A, Bokemeyer C, Lindhofer H, Lahr A, Parsons SL. The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial. Int J Cancer 2010; 127: 2209-2221 [PMID: 20473913 DOI: 10.1002/ijc.25423]
70. Jäger M, Schoberth A, Ruf P, Hess J, Hennig M, Schmalfeldt B, Wimberger P, Ströhlein M, Theissen B, Heiss MM, Lindhofer H. Immunomonitoring results of a phase II/III study of malignant ascites patients treated with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3). Cancer Res 2012; 72: 24-32 [PMID: 22044753 DOI: 10.1158/0008-5472.CAN-11-2235]